Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis
摘要Background:Overexpression and constitutive activation of signal transducer and activator of transcription (STAT) 3 have been suggested in the tumorigenesis of many human cancers,including multiple carcinomas,melanoma,and lymphoma.The diagnosis of hepatocellular carcinoma (HCC) in lobectomy specimens is usually straightforward,but distinguishing cirrhosis from well-differentiated HCC can be challenging in core biopsies.Our aims were to investigate the expression level of STAT3 and phosphorylated STAT3 (pSTAT3) in HCC and cirrhosis,and the application of STAT3 in the differential diagnosis of HCC and cirrhosis.Methods:Sixty cases were divided into three groups:patients with HCC only (Group 1),HCC and cirrhosis (Group 2),and cirrhosis only (Group 3).Formalin-fixed and paraffin-embedded tissue sections were stained immunohistochemically for STAT3,pSTAT3,and CD 163.The values obtained from the tissue sections of each group were compared in statistical analysis.Results:STAT3 showed a high level in HCC and was a significant marker for differentiating HCC from cirrhosis (P < 0.0001).The odds ratio between HCC and cirrhosis increased 34.4 times when the intensity of STAT3 increased by 1 level.Spearman's correlation and Chi-square tests also demonstrated that expression level of STAT3 did not correlate with age,gender,or the presence of a cirrhotic background.Conclusions:STAT3 staining differs significantly in HCC and cirrhosis.The findings reinforce the role of STAT3 in the tumorigenesis of HCC and provide a useful marker to differentiate HCC from cirrhosis in challenging liver biopsies.
更多相关知识
- 浏览18
- 被引1
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



